Related Experiment Videos
Intravascular lymphomatosis--an indolent or aggressive entity?
V Bogomolski-Yahalom1, I S Lossos, E Okun
1Department of Hematology, Hadassah University Hospital and Hebrew University Medical School, Jerusalem, Israel.
Leukemia & Lymphoma
|June 27, 1998
Summary
Intravascular lymphomatosis (IVL) is a rare cancer where lymphoid cells grow in blood vessels. Current therapies show limited success, with a variable clinical course and poor prognosis for patients.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Intravascular lymphomatosis (IVL) is a rare neoplastic disorder characterized by lymphoid cell proliferation within vascular lumens.
- This condition presents diagnostic challenges and often has a poor prognosis.
Observation:
- Four cases of IVL are presented, with diagnoses made through incidental findings post-prostatectomy, skin lesions, and post-mortem examination.
- Autopsy revealed widespread organ involvement, notably in the kidneys, myocardium, gastrointestinal tract, and lymph nodes.
Findings:
- Treatment outcomes were poor, with disease progression and central nervous system involvement observed in most patients.
- One patient achieved a partial response to chemotherapy but relapsed shortly after treatment completion.
Implications:
- The variable clinical course and limited therapeutic options highlight the need for further research into IVL.
- Effective therapeutic strategies are urgently required to improve outcomes for this rare malignancy.